8-K

Company

Nautilus Biotechnology, Inc.

Filed

February 28, 2024

Period of Report

February 28, 2024

Accession Number

0001628280-24-007395

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →